Chronic kidney disease rises while most people with the condition remain unaware

A growing number of Americans have chronic kidney disease, but most remain unaware of it, hampering efforts to prevent irreversible kidney failure requiring dialysis or a transplant, according to a study funded by the National Institutes of Health and published November 7 in the Journal of the American Medical Association.

An estimated 26 million people — about 13 percent of the U.S. population — now have chronic kidney disease, say researchers at Johns Hopkins University in Baltimore, Tufts-New England Medical Center in Boston and Cleveland Clinic Foundation. This new report raises by 3 percent the previous estimate of 20 million people with the disease in 1994.

“Increases in diabetes, hypertension, obesity, and the aging U.S. population explain at least some of the increase,” says co-author Paul W. Eggers, Ph.D., director of kidney disease epidemiology at the National Institute of Diabetes and Digestive and Kidney Diseases, part of the NIH. “We don’t know what may be responsible for the rest.”

The study analyzed and compared National Health and Nutrition Examination Survey data on adults age 20 or older from 1988 to 1994 and 1999 to 2004. More than 15,000 and 13,000 adults, respectively, were interviewed at home and had a physical exam and blood and urine tests. The surveys were conducted by the National Center for Health Statistics, part of the Centers for Disease Control and Prevention.

Kidney function was estimated for each participant with a formula that considers the amount of creatinine in a blood sample, along with age, gender and African American race, which can affect results. Creatinine is a waste product created by normal breakdown of muscle cells during activity. When kidneys are ailing, creatinine builds up in the blood. A small sample of urine was checked for a protein called albumin. Damaged kidneys may persistently leak albumin from the blood into the urine, sometimes even when kidney function appears normal.

Awareness of chronic kidney disease is up, but most people who have the condition still don’t know it. Between 1999 and 2004, survey participants were asked if they had been told they had “weak or failing kidneys.” The authors report that only 11.6 percent of men and 5.5 percent of women with moderate (stage 3) kidney disease knew it. Awareness increased to 22.8 percent among participants with stage 3 disease and albumin in the urine. Awareness was highest among people with severe (stage 4) kidney disease, only 42 percent of whom knew they had the condition. Stage 5 is kidney failure.

“Kidney disease is often silent until late stages, but if we can find it early we can do a lot to prevent kidney failure,” explained Andrew S. Narva, M.D., F.A.C.P., a kidney specialist at the NIH. “If you have diabetes, high blood pressure or a family history of kidney problems you are at risk and should be screened for kidney damage with routine blood and urine tests.”

“To help protect the kidneys’ small blood vessels, carefully control high blood pressure, and blood sugar if you’re diabetic, and ask your doctor if you should take an angiotensin converting enzyme inhibitor or angiotensin receptor blocker,” advised Narva, also director of the NIH’s National Kidney Disease Education Program.

Source: National Institute of Diabetes and Digestive and Kidney Diseases

Related stories:

Researchers find new genetic target for sickle cell disease therapy
Researchers have identified a gene that directly affects the production of a form of hemoglobin that is instrumental in modifying the severity of the inherited blood disorders sickle cell disease and thalassemia. The discovery could lead to breakthrough therapies for sickle cell disease and thalassemia, which could potentially eliminate the devastating and life-threatening complications of these diseases, such as severe pain, damage to the eyes and other organs, infections, and stroke.
Researchers learn that some 'good cholesterol' isn't good enough
If you think your levels of "good cholesterol" are good enough, a new study published in the December 2008 issue of The FASEB Journal suggests that you may want to think again. In the report, researchers from the University of Chicago challenge the conventional wisdom that simply having high levels of good cholesterol (HDL) and low levels of bad cholesterol (LDL) is necessary for good heath. Instead, they show that the good cholesterol has varying degrees of quality and that poor quality HDL is actually bad for you.
Major North American breakthrough for dialysis patients
Suffering from end-stage renal disease (ESRD), a growing number of patients at the Centre hospitalier de l'Université de Montréal (CHUM), have become the beneficiaries of a North American breakthrough: high efficacy hemodiafiltration (HDF).
Study supports value of advanced CT scans to check for clogged arteries
In a development that researchers say is likely to quell concerns about the value of costly computed tomography (CT) scans to diagnose coronary artery blockages, an international team led by researchers at Johns Hopkins reports solid evidence that the newer, more powerful 64-CT scans can easily and correctly identify people with major blood vessel disease and is nearly as accurate as invasive coronary angiography.
Kidney function discovery sheds light on genetic complexity of disease
To find a cure for cancer, haemophilia and other diseases, researchers need to be looking for complex, interacting genetic factors, according to the authors of a new study.
For diabetics, preventing renal failure is hard work but essential
Diabetes has cost Robert Heard dearly. His left leg was amputated below the knee two years ago. Kidney failure - with its special diets, thrice-weekly dialysis, and ever-present threats of infection - is worse.
FDA advisers recommend approval of new gout drug
(AP) -- Government health advisers Monday recommended approval of the first new drug in 40 years for gout, a painful joint disease that mainly strikes middle-aged men.
How Washington hospitals unleashed a MRSA epidemic
Year after year, the number of victims climbed. But even as casualties mounted - as the germ grew stronger and spread inside hospitals - the toll remained hidden from the public, and hospitals ignored simple steps to control the threat.

News discussion:

Medicine & Health news